Pharmacogenomic Research in Korean Patients With Hepatitis C
Pharmacogenomic Research in Korean Patients With Hepatitis C
The aim of this study is to investigate the relationships between drug response and the host
 genetic factors, viral factors and clinical factors in chronic hepatitis C patients (HCV).
 And thus, the investigators are trying to develop the pharmacogenomic guideline in the Korean
 patients with HCV.
Inclusion Criteria:

 -  Hepatitis C virus infected patients

 Exclusion Criteria:

 -  Patients who infected Hepatitis B virus or Human immunodeficiency virus

 -  HCV infected patients previously treated with antiviral drugs

 -  Patients had a history of autoimmune hemolytic anemia